Cytosorbents (CTSO) Misses Q1 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
• Zscaler (ZS) Reiterated at Overweight by Cantor Fitzgerald: Bullish on Red Canary Synergies